Previous Article | Next Article ![]()
Journal of Virology, October 2005, p. 13190-13194, Vol. 79, No. 20
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.20.13190-13194.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Joop Gäken,1
Francisco Martin,2,
Mary Collins,2
Ghulam Mufti,1
Farzin Farzaneh,1* and
David Darling1
King's College London, Department of Haematological and Molecular Medicine, The Rayne Institute, 123 Coldharbour Lane, London SE5 9NU, United Kingdom,1 Department of Immunology and Molecular Pathology, Windeyer Institute of Medical Sciences, University College London, London, United Kingdom2
Received 11 July 2005/ Accepted 18 July 2005
Nonviral producer cell proteins incorporated into retroviral vector surfaces profoundly influence infectivity and in vivo half-life. We report the purification and concentration of lentiviral vectors using these surface proteins as an efficient gene transduction strategy. Biotinylation of these proteins and streptavidin paramagnetic particle concentration enhances titer 400- to 2,500-fold (to 109 CFU/ml for vesicular stomatitis virus G protein and 5 x 108 for amphotropic murine leukemia virus envelope). This method also uses newly introduced membrane proteins (B7.1 and
LNGFR) directed to lentiviral surfaces, allowing up to 17,000-fold concentrations. Particle conjugation of lentivirus allows facile manipulation in vitro, resulting in the transduction of 48 to 94% of human acute myeloid leukemia blasts.
Present address: R&D Office, Institute of Child Health, Great Ormond Street Hospital, 30 Guilford Street, London, United Kingdom.
Present address: IPB Lopez Neyra, Parque tecnológico de la Salud, Avda del conocimiento S/N, Granada 18100, Spain.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»